Home » Meda Acquires Exclusive Rights to New Treatment of Actinic Keratosis
Meda Acquires Exclusive Rights to New Treatment of Actinic Keratosis
Meda has acquired exclusive European rights to a new formulation of imiquimod from Graceway Pharmaceuticals.
StreetInsider
StreetInsider
Upcoming Events
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May